ATYR Competitors & Alternatives
Compare aTyr Pharma, Inc. with similar stocks in the same industry
Biotechnology
ATYR
Main Stock$4.96
-5.34%
Tradestie Score
33
Market Cap
$67.65M
Analyst Upside
+810.6%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.18
+0.37%
|
$154.27M | - | 54 | Compare |
|
OBIO
Orchestra BioMed Holdings, Inc. Ordinary Shares
|
$7.07
-0.70%
|
$137.59M | - | 37 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.63
-3.12%
|
$133.50M | - | 45 | Compare |
|
CGTX
Cognition Therapeutics, Inc. Common Stock
|
$0.63
-1.44%
|
$133.22M | - | 55 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$30.16
-6.68%
|
$117.07M | - | 33 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.11
-7.41%
|
$110.20M | - | 34 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.03
+0.17%
|
$84.52M | - | 53 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.20
-3.74%
|
$67.94M | - | 52 | Compare |
|
IXHL
Incannex Healthcare Limited American Depositary Shares
|
$1.73
-10.36%
|
$40.49M | - | 52 | Compare |
|
ATCH
AtlasClear Holdings, Inc.
|
$0.08
-37.17%
|
$7.15M | 6.6 | 41 | Compare |
More ATYR Analysis
Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry